M Regina De Luna, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 35
- 10 carriers
- Office
- 1
Offices
1 location · Advanced Eye Associates · 3 clinicians in this group
Looking this up.
Plans that list them
35 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Luna’s office at (408) 923-8138 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
35 of 35 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A179602 · Current
Licensed to practise in California · since 2022 · expires 2028-06-30 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$63,415
Medicare paid this office $63,415 for 512 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 169 | $12,812 | $76 |
| New patient complete exam of visual system | 140 | $12,036 | $86 |
| Removal of cataract with insertion of prosthetic lens | 20 | $11,948 | $519 |
| Short return visit (20+ min) | 103 | $7,692 | $69 |
| Return visit (30+ min) | 34 | $5,457 | $114 |
See all 12 services
| New patient visit (30+ min) | 169 | $12,812 | $76 |
| New patient complete exam of visual system | 140 | $12,036 | $86 |
| Removal of cataract with insertion of prosthetic lens | 20 | $11,948 | $519 |
| Short return visit (20+ min) | 103 | $7,692 | $69 |
| Return visit (30+ min) | 34 | $5,457 | $114 |
| Established patient complete exam of visual system | 50 | $3,518 | $65 |
| Established patient problem focused exam of visual system | 51 | $2,466 | $45 |
| New patient visit (45+ min) | 24 | $2,404 | $100 |
| Imaging of optic nerve | 34 | $1,042 | $29 |
| Measurement of corneal curvature and depth of eye | 21 | $916 | $44 |
| Exam of visual field with extended testing | 17 | $861 | $48 |
| Imaging of retina | 25 | $809 | $29 |
Procedures Medicare counted
| Cataract surgery | 27 | More than 51% of doctors who do this |
Who their Medicare patients are
512 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 58% · Also on Medicaid 84% · Health risk score 1.31. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 53% · Chronic kidney disease 25% · Coronary heart disease 18% · Heart failure 12% · COPD 9% · Atrial fibrillation 9% · Depression 9% · Cancer 7% · Dementia 7% · Stroke 6%.
The office billed $221,376, Medicare allowed $111,606 and paid $63,415; for 735 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 512 | 735 | 74 | 1.31 | $221,376 | $63,415 |
| 2023 | 293 | 495 | 74 | 1.29 | $150,115 | $42,429 |
| 2022 | 50 | 63 | 72 | 1.35 | $17,154 | $5,956 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| New patient complete exam of visual system | 138 | $12,579 | $91 |
| Established patient problem focused exam of visual system | 126 | $10,017 | $71 |
| Short return visit (20+ min) | 14 | $1,652 | $83 |
| Imaging of retina | 34 | $1,365 | $32 |
| Established patient complete exam of visual system | 19 | $1,251 | $66 |
| New patient visit (30+ min) | 16 | $874 | $55 |
| Exam of visual field with extended testing | 16 | $863 | $54 |
| Imaging of optic nerve | 25 | $802 | $31 |
| Measurement of corneal curvature and depth of eye | 11 | $340 | $31 |
| Ultrasound scan of cornea to determine thickness | 15 | $145 | $10 |
2022: 2 services
| New patient complete exam of visual system | 13 | $1,642 | $126 |
| Established patient problem focused exam of visual system | 13 | $1,261 | $90 |
Medicaid work
$9,561 in 2024
Medicaid paid $9,561 for 1,044 billed services this clinician did in 2024, up to 53 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 391 | $3,362 |
| New patient visit (30+ min) | 228 | $2,248 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 69 | $1,783 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 249 | $691 |
| Short return visit (20+ min) | 46 | $679 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $420 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $268 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 12 | $72 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 24 | $38 |
| 2024 | 1,044 | 9 | 53 | $9,561 |
| 2023 | 818 | 9 | 42 | $10,037 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 15 | $3,819 |
| New patient visit (45+ min) | 238 | $3,111 |
| New patient visit (30+ min) | 132 | $969 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 61 | $818 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 235 | $581 |
| Short return visit (20+ min) | 42 | $467 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 26 | $131 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 56 | $75 |
| GONIOSCOPY | 13 | $66 |
Drugs they prescribed that Part D paid
$326,033
Pharmacies billed $326,033 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,616) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
808 generic and 808 brand-name prescriptions · $326,033 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 145 | $153,611 | $1,059 |
| Lumigan | 119 | $45,048 | $379 |
| Cyclosporine | 60 | $37,596 | $627 |
| Cequa | 15 | $13,714 | $914 |
| Tyrvaya | 20 | $13,433 | $672 |
See all 18 drugs
| Restasis | 145 | $153,611 | $1,059 |
| Lumigan | 119 | $45,048 | $379 |
| Cyclosporine | 60 | $37,596 | $627 |
| Cequa | 15 | $13,714 | $914 |
| Tyrvaya | 20 | $13,433 | $672 |
| Simbrinza | 36 | $10,014 | $278 |
| Prednisolone Acetate | 197 | $5,150 | $26 |
| Latanoprost | 306 | $3,972 | $13 |
| Brimonidine | 44 | $3,667 | $83 |
| Moxifloxacin | 153 | $3,152 | $21 |
| Besivance | 14 | $3,014 | $215 |
| Travoprost | 16 | $2,263 | $141 |
| Diclofenac | 165 | $1,691 | $10 |
| Timolol Maleate | 89 | $836 | $9 |
| Dorzolamide-Timolol | 43 | $552 | $13 |
| Azelastine | 54 | $476 | $9 |
| Dorzolamide | 20 | $467 | $23 |
| Erythromycin | 45 | $433 | $10 |
Year by year
| 2024 | 1,616 | 405 | 0% (0) | 50% | $326,033 |
| 2023 | 1,084 | 269 | 0% (0) | 55% | $282,061 |
| 2022 | 106 | 59 | 0% (0) | 50% | $16,054 |
| 2021 | 92 | 21 | 0% (0) | 47% | $9,153 |
| 2020 | 11 | None | None | None | $646 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Restasis | 61 | $76,946 | $1,261 |
| Cequa | 48 | $62,298 | $1,298 |
| Cyclosporine | 38 | $21,347 | $562 |
| Lumigan | 37 | $18,373 | $497 |
| Tyrvaya | 18 | $16,847 | $936 |
| Ilevro | 28 | $10,243 | $366 |
| Prolensa | 21 | $7,249 | $345 |
| Besivance | 23 | $5,154 | $224 |
| Latanoprost | 207 | $5,092 | $25 |
| Travoprost | 21 | $4,026 | $192 |
| Prednisolone Acetate | 93 | $3,828 | $41 |
| Brimonidine Tartrate-Timolol | 16 | $3,474 | $217 |
| Combigan | 12 | $3,168 | $264 |
| Brimonidine | 34 | $2,897 | $85 |
| Moxifloxacin | 63 | $2,762 | $44 |
| Loteprednol Etabonate | 15 | $2,652 | $177 |
| Simbrinza | 11 | $2,406 | $219 |
| Azelastine | 35 | $1,264 | $36 |
| Dorzolamide | 33 | $1,154 | $35 |
| Timolol Maleate | 72 | $809 | $11 |
| Diclofenac | 41 | $631 | $15 |
| Erythromycin | 50 | $611 | $12 |
| Dorzolamide-Timolol | 12 | $567 | $47 |
| Olopatadine | 21 | $563 | $27 |
2022: 2 drugs
| Latanoprost | 19 | $881 | $46 |
| Prednisolone Acetate | 15 | $654 | $44 |
2021: 1 drug
| Prednisolone Acetate | 21 | $703 | $33 |
Money from drug and device companies
$649 in 2025
| 2025 | 7 | 24 | None | $649 |
| 2024 | 9 | 31 | None | $703 |
| 2023 | 10 | 36 | None | $1,096 |
| 2022 | 4 | 7 | None | $440 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Lumigan | $211 | 8 payments
|
| Amgen | Tepezza | $200 | 7 payments
|
| Alcon Vision | Rocklatan | $103 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $55 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $32 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $25 | 1 payment
|
See all 24 published payments
| Sun Pharmaceutical Industries | Meals · 2025-09-09 | Cequa | $32 |
| Amgen | Meals · 2025-09-05 | Tepezza | $29 |
| Oyster Point Pharma | Meals · 2025-08-28 | Tyrvaya | $22 |
| Thea Pharma | Meals · 2025-08-22 | Iyuzeh | $24 |
| Abbvie | Meals · 2025-08-21 | Lumigan | $31 |
| Alcon Vision | Meals · 2025-08-08 | Tryptyr | $32 |
| Amgen | Meals · 2025-08-05 | Tepezza | $27 |
| Abbvie | Meals · 2025-08-04 | Lumigan | $30 |
| Amgen | Meals · 2025-07-07 | Tepezza | $30 |
| Alcon Vision | Meals · 2025-06-03 | Rocklatan | $23 |
| Abbvie | Meals · 2025-05-31 | Lumigan | $30 |
| Amgen | Meals · 2025-05-27 | Tepezza | $30 |
| Abbvie | Meals · 2025-05-06 | Lumigan | $29 |
| Alcon Vision | Meals · 2025-04-23 | Rocklatan | $18 |
| Abbvie | Meals · 2025-04-08 | Lumigan | $30 |
| Amgen | Meals · 2025-04-04 | Tepezza | $29 |
| Abbvie | Meals · 2025-04-03 | Lumigan | $14 |
| Bausch & Lomb Americas | Meals · 2025-02-27 | Miebo | $25 |
| Oyster Point Pharma | Meals · 2025-02-26 | Tyrvaya | $32 |
| Abbvie | Meals · 2025-02-22 | Lumigan | $34 |
| Amgen | Meals · 2025-02-03 | Tepezza | $24 |
| Alcon Vision | Meals · 2025-01-22 | Rocklatan | $31 |
| Amgen | Meals · 2025-01-14 | Tepezza | $31 |
| Abbvie | Meals · 2025-01-09 | Lumigan | $12 |
See earlier years (2024, 2023, 2022)
2024: $703
| Amgen | Tepezza | $226 | 10 payments
|
| Sun Pharmaceutical Industries | Cequa | $145 | 7 payments
|
| Alcon Vision | Rocklatan | $78 | 4 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $72 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $60 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $46 | 2 payments
|
| Sight Sciences | Omni Surgical System | $31 | 1 payment
|
| Abbvie | Lumigan | $24 | 1 payment
|
| Bausch & Lomb Americas | Envista Mx60 Iol | $20 | 1 payment
|
2023: $1,096
| Carl Zeiss Meditec USA | Lumera 700 | $400 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $226 | 8 payments
|
| Sun Pharmaceutical Industries | Cequa | $184 | 12 payments
|
| Bausch & Lomb Americas | Vyzulta | $88 | 4 payments
|
| Alcon Vision | Rocklatan | $79 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $27 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $25 | 1 payment
|
| Sight Sciences | Omni Surgical System | $25 | 1 payment
|
| Biotissue Holdings | Prokera | $24 | 1 payment
|
| RxSight | Rxsight Contact Lens | $18 | 1 payment
|
2022: $440
| Oyster Point Pharma | Tyrvaya | $168 | 2 payments
|
| EyePoint Pharmaceuticals US | Yutiq | $124 | 1 payment
|
| Glaukos | Istent | $82 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $66 | 3 payments
|
Professional record
- NPI
- 1144610064
- Licence
- CA A179602California A179602: Current · expires 2028-06-30
- Trained
- Johns Hopkins University School of Medicine, 2018
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Student in a training program (390200000X)
- Mailing address
- 200 Jose Figueres Ave Ste 350, San Jose, CA, 95116
- NPI first listed
- 2015-01-30
- NPI last updated
- 2022-11-08
- NPI record certified
- 2022-11-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.